Medarex

Medarex is developing monoclonal antibody-based therapeutics. Most of the clinical development is through partnerships with larger pharmaceutical companies.

History:

Founded in 1987. They are set to be acquired by Bristol-Meyers Squibb (2009)

Acquisitions:
Ability Biomedical (2005)

Employment

Email:

Fax:

Mail:

General Info:

Ticker: MEDX

Employees:

Regions:
Northern California Northeast

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles: BioSpace

 

News:

Keywords: 

Strategic Partnerships: